Based on the upregulation of Gtl2-Dio3 noncoding RNAs in various cardiac disease models, we next wanted to determine whether their upregulation in diseased hearts reflects their activation in cardiomyocytes and whether they are required for promoting the stress response in cardiomyocytes. This evidence concerns the gene MEG3 and heart disorder.